|
FR2751226B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies du cheval
|
|
FR2775601B1
(fr)
*
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
|
FR2776928B1
(fr)
*
|
1998-04-03 |
2000-06-23 |
Merial Sas |
Vaccins adn adjuves
|
|
WO2000077043A2
(fr)
*
|
1999-06-10 |
2000-12-21 |
Merial |
Vaccins adn pour animaux de compagnie et de sport
|
|
US6645740B1
(en)
*
|
1999-06-10 |
2003-11-11 |
Merial Limited |
Nucleic acids encodings equine GM-CSF
|
|
FR2794648B1
(fr)
*
|
1999-06-10 |
2003-03-07 |
Merial Sas |
Vaccins adn pour animaux de compagnie et de sport
|
|
WO2001083528A2
(en)
*
|
2000-05-01 |
2001-11-08 |
Powderject Vaccines, Inc. |
Nucleic acid immunization
|
|
US6803041B2
(en)
*
|
2001-03-20 |
2004-10-12 |
Boehringer Ingelheim Vetmedica, Inc. |
Equine herpesvirus vaccine
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US7906311B2
(en)
|
2002-03-20 |
2011-03-15 |
Merial Limited |
Cotton rat lung cells for virus culture
|
|
EP2390352A1
(en)
|
2003-03-18 |
2011-11-30 |
Quantum Genetics Ireland Limited |
Systems and methods for improving protein and milk production of dairy herds
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
WO2005049794A2
(en)
|
2003-11-13 |
2005-06-02 |
University Of Georgia Research Foundation, Inc. |
Methods of characterizing infectious bursal disease virus
|
|
EP1718770B1
(en)
|
2004-02-19 |
2011-05-25 |
The Governors of the University of Alberta |
Leptin promoter polymorphisms and uses thereof
|
|
US11865172B2
(en)
|
2005-04-21 |
2024-01-09 |
University Of Florida Research Foundation, Inc. |
Materials and methods for respiratory disease control in canines
|
|
US7959929B2
(en)
|
2005-04-21 |
2011-06-14 |
University Of Florida Research Foundation, Inc. |
Materials and methods for respiratory disease control in canines
|
|
EP2198881A1
(en)
|
2005-04-25 |
2010-06-23 |
Merial Limited |
Nipah virus vaccines
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
EP1951751B1
(en)
|
2005-11-14 |
2017-11-01 |
Merial, Inc. |
Gene therapy for renal failure
|
|
US7682619B2
(en)
|
2006-04-06 |
2010-03-23 |
Cornell Research Foundation, Inc. |
Canine influenza virus
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
AU2007352618B2
(en)
|
2007-05-02 |
2013-07-18 |
Boehringer Ingelheim Animal Health USA Inc. |
DNA plasmids having improved expression and stability
|
|
US20080274137A1
(en)
*
|
2007-05-02 |
2008-11-06 |
Jean Christophe Francis Audonnet |
DNA plasmids having improved expression and stability
|
|
EP3168307B1
(en)
|
2008-11-28 |
2020-07-15 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant avian influenza vaccine and uses thereof
|
|
JP5797636B2
(ja)
|
2009-04-03 |
2015-10-21 |
メリアル リミテッド |
ニューカッスル病ウイルスをベクターとするトリワクチン
|
|
AR079767A1
(es)
|
2009-12-28 |
2012-02-15 |
Merial Ltd |
Antigeno ndv (virus de la enfermedad de newcastle) recombinante y usos del mismo
|
|
US20130197612A1
(en)
|
2010-02-26 |
2013-08-01 |
Jack W. Lasersohn |
Electromagnetic Radiation Therapy
|
|
EP2544716B1
(en)
|
2010-03-12 |
2020-01-01 |
Boehringer Ingelheim Animal Health USA Inc. |
Foot and mouth disease virus recombinant vaccines and uses thereof
|
|
WO2012030720A1
(en)
|
2010-08-31 |
2012-03-08 |
Merial Limited |
Newcastle disease virus vectored herpesvirus vaccines
|
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
|
EP2694677A2
(en)
|
2011-04-04 |
2014-02-12 |
Netherland Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
|
US20140287931A1
(en)
|
2011-04-04 |
2014-09-25 |
Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis |
Methods and compositions for predicting resistance to anticancer treatment
|
|
AU2012245395A1
(en)
|
2011-04-20 |
2013-11-14 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
CA2834288A1
(en)
|
2011-04-25 |
2012-11-01 |
Advanced Bioscience Laboratories, Inc. |
Truncated hiv envelope proteins (env), methods and compositions related thereto
|
|
US20120301479A1
(en)
|
2011-05-27 |
2012-11-29 |
Jean-Christophe Audonnet |
Hendra virus recombinant compositions and uses thereof
|
|
CA2837375C
(en)
|
2011-06-01 |
2019-07-16 |
Merial Limited |
Needle-free administration of prrsv vaccines
|
|
JP6041361B2
(ja)
|
2011-08-12 |
2016-12-07 |
メリアル インコーポレイテッド |
生物学的製品、特にはワクチンの真空保存
|
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
|
NZ722700A
(en)
|
2012-02-14 |
2017-12-22 |
Merial Inc |
Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
|
|
NZ628282A
(en)
|
2012-02-14 |
2016-08-26 |
Merial Inc |
Rotavirus subunit vaccines and methods of making and use thereof
|
|
WO2013138776A1
(en)
|
2012-03-16 |
2013-09-19 |
Merial Limited |
Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
|
|
KR101490292B1
(ko)
|
2012-04-16 |
2015-02-04 |
한국생명공학연구원 |
신규한 ｈ3ｎ8 말 인플루엔자 바이러스
|
|
US10801039B2
(en)
|
2012-06-13 |
2020-10-13 |
The University Court Of The University Of Glasgow |
Reassortant BTV and AHSV vaccines
|
|
WO2014164697A1
(en)
|
2013-03-12 |
2014-10-09 |
Merial Limited |
Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
|
|
WO2016073410A1
(en)
|
2014-11-03 |
2016-05-12 |
Merial, Inc. |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
PH12017502380B1
(en)
|
2015-06-23 |
2022-10-26 |
Merial Inc |
Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
|
|
WO2017031120A1
(en)
|
2015-08-20 |
2017-02-23 |
Merial, Inc. |
Fcv recombinant vaccines and uses thereof
|
|
FI3355915T3
(fi)
|
2015-09-29 |
2024-01-12 |
Boehringer Ingelheim Animal Health Usa Inc |
Koirien parvoviruksen (CPV) viruksen kaltaisten hiukkasten (VLP) rokotteet ja niiden käytöt
|
|
MA43310A
(fr)
|
2015-11-23 |
2021-04-28 |
Boehringer Ingelheim Animal Health Usa Inc |
Protéines de fusion de fmdv et e2 et leurs utilisations
|
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
|
CN109136264B
(zh)
*
|
2018-09-19 |
2022-07-29 |
天康制药(苏州)有限公司 |
马疱疹病毒1型gB-gD融合蛋白、重组载体和真核细胞株及其制备方法和疫苗
|